The Annual General Meeting 2024 in SynAct Pharma AB, Reg.No. 559058-482 (“SynAct”) will take place on Friday May 31, 2024 at CET 10.30 in Stockholm.
Right to participate at the annual general meeting
Shareholders wishing to attend the meeting in person or by proxy must,
- be registered in the Company’s share register kept by Euroclear Sweden AB as of Thursday 23 May 2024, and
- notify their intention to attend the annual general meeting no later than Monday 27 May 2024, by mail to SynAct Pharma AB, Medicon Village, Scheelevägen 2, 223 81 Lund. Notice can also be given by e-mail to [email protected].
The notification shall specify the shareholder’s complete name, address, telephone number, personal identity number or company registration number and the number of shares held by the shareholder. If the shareholder intends to bring advisors to the meeting, the number (maximum two) must be notified to the Company as above.
Nominee-registered shares
Shareholders whose shares are nominee-registered in the name of a bank or other nominee must, to be able to exercise their voting rights at the meeting, request the nominee to register their shares in their own name with Euroclear Sweden AB no later than as of Thursday 23 May 2024. Accordingly, shareholders must well in advance before this date, notify their nominee of their request of such voting rights registration. However, voting rights registrations requested by shareholders and received by the nominee by Monday 27 May 2024 will be taken into account in the preparation of the share register.
Proxy
If the shareholder intends to be represented by a proxy at the meeting, the proxy must bring a written power of attorney, which is dated and duly signed by the shareholder, to the meeting. The validity term of the power of attorney may not be more than five years. If the power of attorney is issued by a legal entity, an up-to-date registration certificate or equivalent document for the legal entity showing the authorized signatory shall be attached. A template power of attorney is available at the Company’s website (www.synactpharma.com) and will be sent to shareholders who request it and state their postal address or e-mail address.
The original power of attorney and, where applicable, registration certificate or equivalent document must be brought to the meeting. In order to facilitate the entrance at the meeting, a copy of the power of attorney and other authorization documents should preferably be attached to the shareholder’s notification to participate in the meeting.